Company Filing History:
Years Active: 2017-2023
Title: Wenzhong Xiao: Innovator in Organ Transplant Biomarkers
Introduction
Wenzhong Xiao is a prominent inventor based in San Jose, CA, known for his significant contributions to the field of organ transplantation. He holds 2 patents that focus on the development of protein and gene biomarkers for the rejection of organ transplants. His work aims to enhance the understanding of transplant rejection mechanisms and improve patient outcomes.
Latest Patents
Wenzhong Xiao's latest patents revolve around methods for determining the transplant category of subjects who have undergone organ transplants. These inventions uncover common mechanisms of rejection injury across different tissue transplants, providing insights for rational drug design. His research examines various tissue sources from patients to understand acute rejection mechanisms through graft biopsies, as well as monitoring through minimally invasive methods such as blood tests or non-invasive means like urine analysis for kidney allografts. The biomarkers identified in his patents include genes, proteins, peptides, and antibodies, which can help classify transplant categories such as acute allograft rejection, stable allograft, BK viremia, BK nephritis, drug toxicity, and chronic allograft injury. Additionally, his patents include compositions, systems, kits, and computer program products that facilitate the application of these methods in various medical contexts.
Career Highlights
Wenzhong Xiao is affiliated with Leland Stanford Junior University, where he continues to advance research in organ transplantation. His innovative work has the potential to significantly impact the field and improve the lives of transplant recipients.
Collaborations
Wenzhong has collaborated with notable colleagues, including Minnie M Sarwal and Tara Sigdel, who share his commitment to advancing medical research in transplantation.
Conclusion
Wenzhong Xiao's contributions to the field of organ transplantation through his patented innovations highlight the importance of biomarker discovery in improving patient care. His work exemplifies the intersection of research and practical application in medicine.